Transcriptomics Identifies a Small Set of Circulating Biomarkers and Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.
BACKGROUND It is sometimes challenging to distinguish hypertrophic cardiomyopathy (HCM) from other cardiomyopathies with left ventricular hypertrophy (LVH). At present, no circulating biomarkers to distinguish HCM have been established. OBJECTIVES The authors aimed to identify plasma microRNA (miRNA) biomarkers uniqu...